MPR Weekly Dose 111 - Allergy Spray OTC Switch; Syringe Malfunction Prompts Recall; Sciatica Pain Tx Update; FDA Alert for COVID-19 Tests; Resubmitted Teplizumab Application Accepted
Allergy treatment gets over-the-counter approval; Anaphylaxis treatment recalled; Phase 3 trial results for investigational sciatica treatment; FDA alert regarding at-home COVID tests; And the resubmi...
25 Mar 202210min
MPR Weekly Dose #110: Interview With Dr Tobias Janowitz
In this week's special episode of The Weekly Dose Podcast we interview Dr Tobias Janowitz, a medical oncologist, assistant professor at the Cold Spring Harbor Laboratories and adjunct professor at the...
18 Mar 202220min
MPR Weekly Dose 109 - Purdue Overdose Treatment Approved; ACIP Immunization Schedules; FDA Provide List of COVID-19 Tests; Urticaria Trial Stopped; First Condom for Anal Intercourse.
A new injection is approved for opioid overdose; The Advisory Committee on Immunization Practices releases vaccine schedules; The FDA provides a list of approved COVID-19 tests; A trial of an investig...
25 Feb 202213min
MPR Weekly Dose 108 - OTC Treatment Shows Benefit in COVID-19; Emergency Use Granted to Antibody; Parkinson Disease Tx Available; Veklury Study Results; Safety Concern for Ketamine
This week in COVID related news, a heartburn medication shows benefit in patients; Bebtelovimab is authroized; Veklury is shown to retain antiviral activity against variants. Away from COVID, a functi...
18 Feb 202214min
MPR Weekly Dose 107 - Millions of Molnupiravir Courses Delivered; Guidance on Nonopioid Analgesic Development; Enteral Feeding Tube Warning; Enjaymo Approved; Mecarbil Under Review for HFrEF
This week: news of millions of courses of a COVID-19 oral antiviral being provided to the US government for distribution throughout the country; There's a draft guidance for novel nonopioid analgesics...
11 Feb 202210min
MPR Weekly Dose 106 - FDA Approves COVID-19 Vaccine; EUA Submission for Kids Under 5; COVID Tests Recalled; Vupanorsen Development Ends; Cabenuva Approval Expanded
This week: The approval of a second COVID-19 vaccine; Pfizer and BioNTech submit for Emergency use of their vaccine for children under 5; Pfizer have also stopped development on a potential drug treat...
3 Feb 202213min
MPR Weekly Dose 105 - Antibody Therapies Restricted; Veklury Greenlit for Outpatients; Parsaclisib Indication Withdrawn; Pepaxto Withdrawal Reconsidered; Kimmtrak Approved
Use of monoclonal antibodies restricted due to Omicron; Veklury given the go-ahead as an outpatient treatment; New data produces a reconsideration for Pepaxto withdrawal; And there's a new treatment a...
28 Jan 202211min
MPR Weekly Dose 104 - Two New Atopic Dermatitis Therapies; Counterfeit HIV; Indications Withdrawn for Zydelig; CDC Pediatric Influenza Vaccine Study Results; COVID Test Warning
This week we have news of two new approval for atopic dermatitis; Warnings around counterfeit HIV treatments; Zydelig indications withdrawn; CDC pediatric influenza vaccine study results; And an FDA w...
20 Jan 202212min
